Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis

BACKGROUND: To date, no reliable serum marker for clear cell renal cell carcinoma (CCRCC) is available. The aim of this study was to evaluate the putative significance of circulating 20S proteasome levels. METHODS: Preoperative 20S proteasome serum levels were determined in 113 CCRCC patients and 15...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: de Martino, M, Hoetzenecker, K, Ankersmit, H J, Roth, G A, Haitel, A, Waldert, M, Klatte, T
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2012
Gaiak:
Molecular Diagnostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3305962/
https://ncbi.nlm.nih.gov/pubmed/22294183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.20
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak